Hypophosphorylation of Mdm2 augments p53 stability

Molecular and Cellular Biology

Volumn 22, Issue 17, 2002, Pages 6170-6182

  Blattner, Christine ^a   Hay, Trevor ^a   Meek, David W ^a   Lane, David P ^a  

^a KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MUTANT PROTEIN; PROTEIN MDM2; PROTEIN P14; PROTEIN P53; UBIQUITIN PROTEIN LIGASE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IONIZING RADIATION; PEPTIDE MAPPING; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; CARCINOMA; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; COS CELLS; CYSTEINE ENDOPEPTIDASES; FIBROBLASTS; GAMMA RAYS; HUMANS; LUNG NEOPLASMS; MICE; MOLECULAR SEQUENCE DATA; MULTIENZYME COMPLEXES; MUTAGENESIS, SITE-DIRECTED; NUCLEAR PROTEINS; PEPTIDE MAPPING; PHOSPHORYLATION; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; RECOMBINANT FUSION PROTEINS; SEQUENCE DELETION; SPECIES SPECIFICITY; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITIN;

EID: 0036340096     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.22.17.6170-6182.2002     Document Type: Article

References (42)

1. The contribution of the acidic domain of MDM2 to p53 and MDM2 stability
2. The role of p53 in tumor suppression: Lessons from mouse models
3. Regulation of mdm2 expression by p53: Alternative promoters produce transcripts with non-identical translation potential
4. Transcription factor E2F-1 is upregulated in response to DNA damage in a manner analogous to that of p53
5. Design of a synthetic Mdm2-binding mini protein that activates the p53 response in vivo
6. Molecular analysis and chromosomal mapping of amplified genes isolated from a transformed mouse 3T3 cell line
7. High efficiency transformation of mammalian cells by plasmid DNA
8. Mapping of the p53 and mdm-2 interaction domains
9. Mechanisms of ubiquitin-mediated, limited processing of the NF-kappaB1 precursor protein p105
10. The ubiquitin mediated proteolytic pathway: Mode of action and clinical implications
11. The Li-Fraumen syndrome: An inherited susceptibility to cancer
12. p300/MDM2 complexes participate in MDM2-mediated p53 degradation
13. Mdm2 promotes the rapid degradation of p53
14. Multiple sites of in vivo phosphorylation in the MDM2 oncoprotein cluster within two important functional domains
15. Characterization of sequence elements involved in p53 stability regulation reveals cell type dependence for p53 degradation
16. Phosphorylation of murine double minute clone 2 (MDM2) protein at serine-267 by protein kinase CK2 in vitro and in cultured cells
17. Association of p19ARF with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53
18. Oncoprotein Mdm2 is a ubiquitin ligase E3 for tumor suppressor p53
19. RB regulates the stability and the apoptotic function of p53 via Mdm2
20. Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage
21. Regulation of p53 stability by Mdm2
22. N-terminal 130 amino acids of MDM2 are sufficient to inhibit p53-mediated transcriptional activation
23. Ubiquitination of p53 and p21 is differentially affected by ionizing and UV radiation
24. Twenty years of p53 research: Structural and functional aspects of the p53 protein
25. ATM-dependent phosphorylation of Mdm2 on serine 395: Role in p53 activation by DNA damage
26. Analysis of multi-site phosphorylation of the p53 tumor-suppressor protein by tryptic phosphopeptide mapping
27. An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo
28. Analysis of p53 expression in human tumours: An antibody raised against human p53 expressed in Escherichia coli
29. MDM2-master regulator of the p53 tumor suppressor protein
30. The mdm2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
31. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53
32. Regulation of the p53 tumor suppressor protein
33. The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53
34. Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation
35. The cellular response to p53: The decision between life and death
36. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2
37. p53: A frequent target for genetic abnormalities in lung cancer
38. Ubiquitin-dependent c-Jun degradation in vivo is mediated by the δ-Domain
39. Phosphopeptide mapping and phosphoamino acid analysis by electrophoresis and chromatography on thin-layer cellulose plates
40. Conformational changes in p53 analyzed using new antibodies to the core DNA binding domain of the protein
41. Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA) - Structural conservation and the detection of a nucleolar form
42. Nucleolar Arf sequesters Mdm2 and activates p53